Shield Corp Ltd
Shield Corp Ltd operates in the Personal Products industry, manufacturing and selling personal care products to consumers, primarily generating revenue through product sales.
Business. Shield Corp Ltd (SCL.PSX) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items and is headquartered in Pakistan. It is primarily listed on the Pakistan Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not disclosed.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Shield Corp Ltd (SCL.PSX) is a personal products company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of personal care items and is headquartered in Pakistan. It is primarily listed on the Pakistan Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not disclosed.
Shield Corp Ltd's capital structure is highly leveraged, with a debt-to-equity ratio of 1.89, indicating significant reliance on debt financing. The company's liquidity position is medium risk, with a current ratio of 0.71, suggesting limited short-term liquidity to cover immediate obligations. Despite a negative net income of PKR -198.25 million, the company generated positive operating cash flow of PKR 232.20 million, which partially offsets the free cash flow deficit of PKR -213.88 million.
Profitability metrics are weak, with a return on equity of -31.16% and a return on assets of -7.26%, both significantly below industry norms. The company's operating margin is negative at -25.45%, and its net margin is -32.05%, indicating poor cost control and pricing power. These metrics suggest the company is underperforming relative to its peers in the Personal Products industry.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution.
Growth trajectory is negative, with a net income decline of 32.05% and an operating income decline of 25.45% in the latest period. The company's capital expenditures of PKR -209.30 million suggest ongoing investment in operations, but the negative free cash flow indicates that these investments are not yet generating sufficient returns.
The company faces moderate liquidity risk due to its current ratio of 0.71 and a negative net cash position after subtracting total debt. The dilution risk is low, with no significant dilution sources identified in the latest filings. However, the company's negative net income and high debt levels may necessitate future equity or debt financing, which could introduce dilution risk.
Recent filings and transcripts indicate ongoing operational challenges, including cost overruns and supply chain disruptions. The company has not disclosed any major strategic initiatives or product launches in the latest reports, which may impact its ability to reverse its current financial trajectory.
- Shield Corp Ltd is highly leveraged with a debt-to-equity ratio of 1.89, indicating significant financial risk.
- The company's profitability metrics are poor, with a return on equity of -31.16% and a return on assets of -7.26%.
- The company's revenue is concentrated in a single business segment, increasing exposure to regional or sector-specific risks.
- Growth is negative, with a net income decline of 32.05% and an operating income decline of 25.45%.
- The company faces moderate liquidity risk and may require additional financing to sustain operations.
Bull / Bear case
Generated · model-assistedFree cash flow surged 97.9% year-over-year to PKR 148.3 million, indicating significant improvement in cash generation capabilities.
Net income increased 96.5% year-over-year, demonstrating a strong recovery in profitability compared to the prior fiscal period.
Long-term debt decreased significantly from PKR 1.39 billion in FY-3 to PKR 673.9 million in FY-4, reducing leverage.
Revenue maintained a positive 4-year CAGR of 8.4%, suggesting underlying long-term growth potential despite recent volatility.
Dilution risk is assessed as low, providing some stability for existing shareholders regarding equity structure changes.
Credit risk is flagged as high, suggesting substantial potential for financial distress or default issues for the issuer.
Debt-to-equity ratio of 1.89 is in the bottom quartile, indicating excessive leverage relative to peer companies.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- VP and GM Surfactants-INT · Restricted Stock Units → Restricted Stock UnitsDisposed 90exercise · 2026-05-11
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 550exercise · 2026-05-01
- VP and GM Surfactants NA · Restricted Stock Units → Restricted Stock UnitsAcquired 2 621grant · 2026-04-13
- VP and GM Surfactants-INT · Performance Shares → Common StockAcquired 1 429grant · 2026-04-13
- VP and GM Surfactants NA · Performance Shares → Common StockAcquired 1 310grant · 2026-04-13
- VP and GM Surfactants NA · Stock Appreciation Right → Common StockAcquired 3 694 @ $52,46grant · 2026-04-13
- VP and GM Surfactants-INT · Restricted Stock Units → Restricted Stock UnitsAcquired 2 859grant · 2026-04-13
- VP and GM Surfactants-INT · Stock Appreciation Right → Common StockAcquired 4 030 @ $52,46grant · 2026-04-13
- Director, President & CEO · Restricted Stock Units → Restricted Stock UnitsDisposed 857exercise · 2026-03-04
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 571exercise · 2026-03-04
- V.P. and Gen'l. Mgr., Polymers · Restricted Stock Units → Restricted Stock UnitsDisposed 429exercise · 2026-03-04
- VP & GM Surfactants · Restricted Stock Units → Restricted Stock UnitsDisposed 571exercise · 2026-03-04
- VP & GM Surfactants · Restricted Stock Units → Restricted Stock UnitsDisposed 1 670exercise · 2026-03-03
- V.P. and Gen'l. Mgr., Polymers · Restricted Stock Units → Common StockDisposed 1 253exercise · 2026-03-03
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 1 670exercise · 2026-03-03
- Director, President & CEO · Restricted Stock Units → Common StockDisposed 4 455exercise · 2026-03-03
- VP & GM Surfactants · Performance Shares → Common StockAcquired 2 247grant · 2026-03-02
- VP GC & Secretary · Restricted Stock Units → Restricted Stock UnitsAcquired 4 495grant · 2026-03-02
- VP GC & Secretary · Performance Shares → Common StockAcquired 2 247grant · 2026-03-02
- VP GC & Secretary · Stock Appreciation Right → Common StockAcquired 6 440 @ $17,47grant · 2026-03-02
- VP & CHRO · Restricted Stock Units → Restricted Stock UnitsAcquired 4 495grant · 2026-03-02
- VP & CHRO · Performance Shares → Common StockAcquired 2 247grant · 2026-03-02
- VP & CHRO · Stock Appreciation Right → Common StockAcquired 6 440 @ $17,47grant · 2026-03-02
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsAcquired 5 993grant · 2026-03-02
- EVP, Supply Chain · Performance Shares → Common StockAcquired 2 996grant · 2026-03-02
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Shield Corp Ltd Market data — financials · 2026-05-29
Ownership & reference
Leadership
- M. Haroon QassimChief Executive Officer, Executive Director
Insider activity
- VP and GM Surfactants-INT · Common StockOther 90 @ $52,58$5K · 2026-05-11
- VP and GM Surfactants-INT · Common StockOther 50 @ $52,58$3K · 2026-05-11
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- EVP, Supply Chain · Common StockOther 550 @ $50,33$28K · 2026-05-01
- EVP, Supply Chain · Common StockOther 162 @ $50,33$8K · 2026-05-01
- Director, President & CEO · Common StockOther 857 @ $49,62$43K · 2026-03-04
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 149 @ $49,62$7K · 2026-03-04
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 429 @ $49,62$21K · 2026-03-04
- Director, President & CEO · Common StockOther 252 @ $49,62$13K · 2026-03-04
- VP & GM Surfactants · Common StockOther 166 @ $49,62$8K · 2026-03-04
- EVP, Supply Chain · Common StockOther 168 @ $49,62$8K · 2026-03-04
- EVP, Supply Chain · Common StockOther 571 @ $49,62$28K · 2026-03-04
- VP & GM Surfactants · Common StockOther 571 @ $49,62$28K · 2026-03-04
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 434 @ $48,98$21K · 2026-03-03
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 1 253 @ $48,98$61K · 2026-03-03
- Director, President & CEO · Common StockOther 4 455 @ $48,98$218K · 2026-03-03
- Director, President & CEO · Common StockOther 1 306 @ $48,98$64K · 2026-03-03
- EVP, Supply Chain · Common StockOther 1 670 @ $48,98$82K · 2026-03-03
- EVP, Supply Chain · Common StockOther 490 @ $48,98$24K · 2026-03-03
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -0.9%Derived (calculated)
- Gross margin (FY 2025-12-31): 11.6%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -6.8%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 0.2%Derived (calculated)
- Net margin (FY 2025-12-31): 2.0%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -0.2%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 33.1%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 2.3%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 6.3%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 7.0%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 3.7%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 11.4%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -8.7%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -6.9%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -7.2%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 8.1%Derived (calculated)
- Return on assets (FY 2025-12-31): 2.0%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.29xDerived (calculated)
- Return on equity (FY 2025-12-31): 3.8%Derived (calculated)
- Cost of revenue (annual): USD 2.06BSEC XBRL filing
- Net income (annual): USD 46.9MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 2SEC XBRL filing
- Revenue (annual): USD 2.33BSEC XBRL filing
- Pre-tax income (annual): USD 59.9MSEC XBRL filing